What is Nanomedicine?
Nanomedicine is the application of Nanotechnology (materials with sizes in the nanometre range, i.e. 10-9 m) to promote innovation in Healthcare. Nanomedicine is a revolutionary interdisciplinary science, which combines knowledge from Pharmacy, Physics, Biology, Chemistry and Medicine to treat conditions and diseases of the human body at a molecular level. Nanomedicine has many applications, from drug therapy and diagnostics to individual cell repair, to artificial tissues and radiation therapy. Our NANOMED EMJMD is focusing on the drug delivery applications of Nanomedicine.
What is an EMJMD?
Erasmus Mundus Joint Master Degrees (EMJMDs) are highly integrated study programmes that are delivered by an international Consortium of Higher Education Institutions. They aim at fostering excellence, innovation, and internationalisation in Higher Education Institutions. The EMJMDs are supported by the EACEA (Education, Audiovisual and Culture Executive Agency) of the European Commission and are part of the Erasmus + programme.
You can participate to an EMJMD as a scholarship student or as a self-funded student. To learn more about the application procedure please click here.
The Nanomedicine for Drug Delivery, or in short NANOMED EMJMD, is a 22-months-long curriculum offering a high quality and multidisciplinary education in the emerging field of Nanomedicine. All courses will be taught in English.
The design of nanomedicines for drug delivery requires combining knowledge from Pharmacy, Biology, Chemistry, Medicine, Physics and Engineering which makes the NANOMED EMJMD a highly multidisciplinary Master’s degree. The frame of the EMJMD has thus been elaborated in order to be able to welcome students from different backgrounds who would show an interest in the field of Nanomedicine.
The NANOMED EMJMD provides both theoretical and practical knowledge for 3 semesters (Semesters 1, 2 and 3, 30 ECTS each) combined with a final traineeship (Semester 4, 30 ECTS).